Product Recalls in Louisiana

Product recalls affecting Louisiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Louisiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,678 recalls have been distributed to Louisiana in the last 12 months.

51,202 total recalls
2,678 in last 12 months

Showing 79217940 of 13,548 recalls

DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride 250 mL Bag Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: morphine sulfate 1 mg per mL in 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: ePHEDrine Sulfate 5 mg/mL in NS 5 mL Fill in 12 mL Syringe (25 mg) Recalled...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL as citrate 5 mcg/mL in 0.9% Sodium Chloride 1 mL in Single Dose...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine 10 mg in 0.9% Sodium Chloride 250 mL bag Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: BUPIVacaine HCl 0.2% IN 0.9% Sodium Chloride 250 mL Bag Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: NORepinephrine 4 mg in 0.9% Sodium Chloride 250 mL from Stock Recalled by...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: BUPIVacaine HCl 0.1% PF (From 0.75%) in 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: Potassium Chloride 20 meq Added to Sodium Chloride 0.9% 250 mL Recalled by...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: NORepinephrine Bitartrate 16 mg in 0.9% Sodium Chloride 250 mL from Stock...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 25 mg in 0.9% Sodium Chloride 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine 100 mg in 0.9% Sodium Chloride 250 mL Bag Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 3 mcg/mL + BUPIvacaine 0.1% in 0.9% Sodium Chloride 250 mL Recalled...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: EPINEPHrine HCl 4 mg in 0.9% Sodium Chloride 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Chlorhexidine Gluconate Oral Rinse Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Pfizer Inc.

Recalled Item: Deferoxamine Mesylate for injection Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm failed to control impurity for color change at the API...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q4 Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q2 Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 11, 2017· Dr. Reddy's Laboratories, Inc.

Recalled Item: Pravastatin Sodium Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications: high out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund